Ryght CEO Simon Arkell and Professor Mark Hutchinson (left) at IPAS
As part of a burgeoning strategic partnership, the University of Adelaide and California-based leading enterprise generative AI (GenAI) technology company Ryght have signed an MOU that will help to lift South Australia’s capability in the artificial intelligence sector.
The collaboration will provide the University with access to the Ryght AI platform to enable and accelerate the adoption of artificial intelligence (AI) use cases across grant and industry-funded local, state and federal government initiatives – all from an Adelaide hub.
The partnership will further help establish South Australia as a leader in the Australian AI and biotech industries. It will foster collaborative research, development, and commercialisation initiatives between the two parties.
As a leader in health and life sciences, the University of Adelaide contributes significantly to Adelaide BioMed City. Adelaide BioMed City’s extensive health datasets will be instrumental in harmonising Ryght’s software platform with these data assets, thereby enhancing the platform’s capabilities and South Australia’s effectiveness in the health and life sciences sectors.
Professor Anton Middelberg, Deputy Vice-Chancellor and Vice-President (Research) said that the University’s partnership with Ryght exemplifies its commitment to advancing world-class research that addresses societal challenges.
“Ryght’s expertise in GenAI aligns perfectly with the University of Adelaide’s strengths in health and life sciences, particularly within the Adelaide BioMed City precinct,” said Professor Middelberg.
“This partnership will provide Ryght with access to highly qualified AI researchers from the University of Adelaide who are embedded in clinical and biomedical research, giving the company an edge in the competitive race to work with the best AI talent.”
Professor Mark Hutchinson, Simon Arkell and Professor Middelberg (left to right) at the MOU signing.
The partnership with Ryght will provide a locally managed, sovereign, secure, and industry-tuned AI software platform to accelerate groundbreaking AI, research, and innovation. The University of Adelaide’s Australian Institute for Machine Learning (AIML) is at the forefront of AI research, further enhancing its reputation as a leader in technology and innovation.
California-based Simon Arkell, the Co-founder and CEO of Ryght and a two-time Australian Olympian, shared his excitement about the partnership.
“As an Adelaide native now based in Silicon Valley, I am thrilled to introduce Ryght’s advanced AI technology to my homeland,” he remarked.
“One of my co-founders, Alex, and I both proudly attended the University of Adelaide, making this collaboration with the University a major milestone for us and for Ryght.
“It also holds the promise of positioning South Australia as a global leader in AI, research, and biotechnology. By merging our technological prowess with the University’s exceptional research capabilities, we aim to foster a dynamic AI ecosystem that will drive innovation and tackle critical public health issues.”
Through this partnership, Ryght and the University of Adelaide will engage in a variety of collaborative activities. These include accelerating research projects, developing new AI models, applications, and workflows, and deploying solutions nationwide at scale in a fully secure environment to solve some of the country’s biggest challenges.
The University of Adelaide’s Professor Mark Hutchinson, Interim Director of the Institute for Photonics and Advanced Sensing (IPAS) and a Professor of Biomedicine, leads the University’s Neuroimmunopharmacology laboratory.
“By working together with Ryght, we can leverage our collective expertise to develop innovative, responsible and tested solutions for better public health and other critical issues and bring Australia’s AI capabilities up to world-class standards where they belong,” said Professor Hutchinson.
“We are excited about the opportunities this collaboration brings and look forward to the significant real-world impact it will have on our communities and beyond.”
About the University of Adelaide
The University of Adelaide unites and serves those striving to change the world-and themselves-for the better. It’s a place where history is made. Established in 1874, we’re home to over 29,000 students and 3,000 staff, all striving to create progress. For our community. For all. This is a university of outstanding quality-ranked as a top 100 global university-in the heart of the city of Adelaide. We were our country’s first university to welcome female students. The first to teach science and business. Our alumni have won Nobel Prizes, led the nation, and walked in space.
About Ryght
Ryght is a privately held healthcare technology company based in Anaheim, California, that is developing the next generation of safe and secure generative artificial intelligence (GenAI) solutions for the biopharma industry. The Ryght platform leverages and optimises multiple large language models (LLMs) and vector databases to ingest real-time data streams and make actionable knowledge directly available to biopharma discovery, clinical, and commercial teams. The platform enables healthcare professionals to rapidly leverage the power of GenAI within compliance of data security standards required by the industry.
